July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Mechanisms of transcriptional regulation of ARMS2/HTRA1 locus as risk factor for age-related macular degeneration
Author Affiliations & Notes
  • Takeshi Iwata
    National Inst of Sensory Organs, Tokyo Medical Center, Natl Hospital Organization, Tokyo, Japan
  • Daisuke Iejima
    National Inst of Sensory Organs, Tokyo Medical Center, Natl Hospital Organization, Tokyo, Japan
  • Mao Nakayama
    National Inst of Sensory Organs, Tokyo Medical Center, Natl Hospital Organization, Tokyo, Japan
  • Footnotes
    Commercial Relationships   Takeshi Iwata, None; Daisuke Iejima, None; Mao Nakayama, None
  • Footnotes
    Support  AMED Grant (Japan), JSPS Grant (Japan), NHO Grant (Japan)
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4901. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Takeshi Iwata, Daisuke Iejima, Mao Nakayama; Mechanisms of transcriptional regulation of ARMS2/HTRA1 locus as risk factor for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4901.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Age-related macular degeneration (AMD) is a leading cause of vision loss and blindness in the elderly. ARMS2/HTRA1 haplotype is well known as the major risk factor for AMD (De Wan et al., Science 2006). But, the molecular mechanism, which derived the disease onset by the ARMS2/HTRA1 haplotype is still unclear. Our previous studies suggest that the insertion/deletion (indel) sequence located 3.8 kb upstream of HTRA1 gene is functionally association with the disease onset. Approximately 2-3-fold increase of promoter activity was observed for indel HTRA1 promoter compared to control sequence (Iejima et al., JBC 2015). Furthermore, we created transgenic mice ubiquitously overexpressing mouse HtrA1 using the chicken actin promoter (CAG) leading to choroidal neovascularization (CNV) similar to wet AMD patients (Nakayama et al., IOVS 2014). These experimental results suggest that the human HTRA1 expression is enhanced by indel haplotype in the enhancer region of HTRA1 gene, and this enhanced HTRA1 may be related to the induction of retinal neovascularization.

Methods : To elucidate the HTRA1 gene expression mechanism by the indel haplotype, transcriptional factors involved with this region was investigated. Double strand DNA probe was designed based for the normal and indel sequence and Electrophoresis Mobility Shift Assay (EMSA) was performed. The same probe was used to isolate binding transcription factors and to determine the peptide sequence using liquid chromatography-mass spectrometry (LC-MS/MS).

Results : Transcriptional proteins specifically binding to the indel sequence was determined by LC-MS/MS. One of the top-hit candidate transcription factor protein is the General Transcription Factor IIi (GTF2I), which was detected by anti-GTF2I antibody against western blot of the EMSA assay. The SNPs associated with AMD is located in the linkage disequilibrium (LD) block, which expands from first exon of ARMS2 to the first exon of HTRA1 gene.

Conclusions : Our data suggests that the haplotype in this region containing both gene is associated with the enhancement of human HTRA1 expression regulated by different transcription factors. Transcription factor GTF2I, which likely to be involved in the enhancement was isolated and peptide sequence determined by LC-MS/MS.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×